Is 2022 the Endemic Year?

The bottleneck in the artificial intelligence (AI) buildout is neither capital nor demand, but rather the operational capability to develop land, secure a grid connection, and build the power supply, says Brookfield Asset Management CEO Connor Teskey on Goldman Sachs Exchanges: G ...  Show more

With the right “rules of the road,” advancing AI doesn’t have to be a choice between innovation and safety, says David Solomon, chairman and CEO of Goldman Sachs. He also explains why he’s optimistic about AI’s impact on the job market in this episode of the Exchanges podcast. Ke ...  Show more

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Rec ...

Dr. Brian Goldman speaks with infectious diseases physician Dr. Zain Chagla about omicron, the new coronavirus variant of concern. 

Many experts warn there will be more infections on the downslope of the omicron surge, but the U.S. is on the path to the virus becoming endemic — and that should mean fewer interruptions to daily life. Take a listen to Rachel Martin chat with health correspondent Allison Aubrey ...  Show more